XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 30.98

+3.9%

Dec 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (15382)	6/21/2001 7:39:06 PM
From: Cacaito	Read Replies (1) of 17367

Xanelim tentative for Q401 or Q102, these the market did not like, and it seems that they knew couple of weeks ago, when the selloff in xoma began. They also knew (and Barron's and the TSC alerted well)the superior aspects of Amevive and Biogen alleged and expected earlier BLA (they do have long term data). For me products are similar, except the long term responses on Amevive, these were probably few subjects, otherwise Biogen will have flaunted the numbers like a royal turkey the feathers. Market is indeed manipulated, dumping xoma for this is plain garbage, but that is the reality when a biotech is overvalue, and xoma is very overvalue for the 2003 prospect of selling a me too 2nd tier product

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next